Dehydration during exercise may contribute to CRVO

• by Andrea Surnit

• October 15, 2026

FDA clears targeted cholangiocarcinoma therapy

In the single-arm REFOCUS trial, 46% of patients responded to treatment, with a median response duration of 11.8 months.

• by Kathryn Wighton

• September 24, 2026

• 2 min

Assessing the Impact of Systemic Hypertension on Retinal Microvasculature, Optic Nerve Head, and Visual Fields Through Optical Coherence Tomography Angiography and Visual Field Analysis

• by Salma Maged Mohammed Mohammed El-Maghrabi, Rafik Mohamed Fouad El Ghazawy, Hisham Mohamed Khairy Abdel Dayem, Al Hussein Aly Mohamed Swelem, Passant Sayed Saif

• November 21, 2025

The Retina’s Lost Lipid Signal

High-resolution metabolomics identifies erucamide depletion in retinal degeneration and links restoration to neurovascular rescue

• June 30, 2026

• 2 min